Adalimumab for the treatment of fistulas in patients with Crohn's disease - Wikidata - wikimedia - TriplyDB

Adalimumab for the treatment of fistulas in patients with Crohn's disease

Adalimumab for the treatment of fistulas in patients with Crohn's disease

http://www.wikidata.org/entity/Q37209889

about

Adalimumab in the management of Behçet's disease Management of complex perianal Crohn's disease Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE.Endoscopic ultrasound to guide the combined medical and surgical management of pediatric perianal Crohn's disease.Multidisciplinary and evidence-based management of fistulizing perianal Crohn's disease.Impact of medical therapy on patients with Crohn's disease requiring surgical resection.The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Highlights from digestive disease week 2010.Efficacy and complications of surgery for Crohn's disease Adalimumab - an effective and promising treatment for patients with fistulizing Crohn's disease: a case series Current and emerging drugs for the treatment of inflammatory bowel disease.Intestinal-specific TNFα overexpression induces Crohn's-like ileitis in mice Efficacy and safety of adalimumab for the Crohn's disease: a systematic review and meta-analysis of published randomized placebo-controlled trials.Update on the management of inflammatory bowel disease: specific role of adalimumab.Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial.Management of perianal fistulas in Crohn's disease: an up-to-date review Surgical treatment of anorectal crohn disease.Modern Treatments and Stem Cell Therapies for Perianal Crohn's Fistulas.AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study Overview of biologic therapy for Crohn's disease.Emerging treatments for complex perianal fistula in Crohn's disease Immunosuppressive therapies for inflammatory bowel disease.Second Korean guidelines for the management of Crohn's disease.Management of Crohn's disease in poor responders to adalimumab.What is the optimal therapy for Crohn's disease: step-up or top-down?T-cell-directed therapies in inflammatory bowel diseases.Use of biological molecules in the treatment of inflammatory bowel disease.Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.Assessing response and loss of response to biological therapies in IBD.Immunopathological characteristics of cryptoglandular and Crohn's anorectal fistulas.An evidence-based systematic review on medical therapies for inflammatory bowel disease.Managing Perianal Crohn’s Disease.First-line therapies in inflammatory bowel disease.Treatment of fibrostenotic and fistulizing Crohn's disease.First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab Comparing medical treatments for Crohn's disease.Therapeutic peptides in inflammatory bowel disease.Novel agents in the future: Therapy beyond anti-TNF agents in inflammatory bowel disease.

P2860

Q26861428-1874242D-090D-44F1-BAD0-FB04A9939B06 Q30239850-DD95888F-C74D-4185-9DE6-A41A8D035E12 Q30679247-ED100BD6-195E-45B0-A9C8-CD0F40F80990 Q33856389-FCDED804-9590-423B-85F0-E17B42B45DB2 Q34048010-E6A3809A-7F94-4B28-85F0-D417ECF50395 Q34137388-1A2B3076-2321-44B9-B8DD-0C8C6324C33F Q34147687-F059F733-6E33-465C-BBC1-FA1C788F1E3E Q34152778-AE3749F3-6BD0-4F1E-A65F-4D22C2B9CFDD Q34178540-6D4F1099-ECCB-4AB1-B855-5FD82EBD0B1F Q34293341-A88E64D2-4B23-413F-96D4-7FB25B855495 Q34764854-10872B01-48A8-4A5A-89FA-605AEC6A317A Q34883210-79E4A60D-7768-4FC0-A8B5-1A18859EC1B7 Q34973958-C55E2843-93F7-4BB0-A890-2B53670053B7 Q35177220-A6FAFE49-8B27-4176-A3F8-71AA7FA3BC88 Q35186975-1EEDCFDD-7E88-4A80-AFD0-386C5DEC3CB2 Q35268107-9DC2D445-394F-4C68-986F-AF90C730AD7D Q35558085-F1FEF989-1F26-4A2C-97D3-AED6A655235E Q37007911-ED1CAA43-0FD4-48C1-AD06-1F6C7CC7239A Q37521494-7F732500-A9CE-4A9C-A742-57A9A30C0EAE Q37523477-7D6CD735-19C7-45EE-A784-E74C2F1115A2 Q37547257-B0B27876-3082-4F9C-B7C2-31E0ACC95AF4 Q37596324-2EEBE46B-B9BE-43D1-8A91-62050732BF09 Q37660661-C05F088F-3B88-4605-B3D8-D04F8D2DB079 Q37662498-79042A1D-67B0-4FB1-8345-B82DC9622C31 Q37708656-E7BDCAF6-F3C7-4AED-948D-47378A625A40 Q37720746-23337704-0C61-4008-A900-91B5D301ED83 Q37720783-1C502B50-77C6-4C06-8341-EFBA6D7FC696 Q37829470-60ED8247-2D4C-436E-A38F-F492F0A5EB53 Q37853359-B7804687-9540-46EA-A55C-F1FCCD9C5717 Q37856191-2F56DED1-A299-4B15-BF6F-CF953871EA0D Q37861167-415B8A9A-BDEB-4E59-8F93-B7AE704AE3D2 Q37862584-2618BE4B-9907-4A66-88D3-1A0B57789CC8 Q37981120-74A2E3AF-D5D2-4A1B-8DC4-B03CDBA12520 Q38050878-95E368B5-0CDF-43F3-B027-9B2FA4AE50CB Q38050883-8A1BC3BE-9A6E-4AA3-9EF4-32D22E2061E1 Q38086355-1AD3FA97-564F-429D-A15C-34545A094A93 Q38102982-7145F72D-0EE3-42C1-BA9D-31B6617F3558 Q38162880-60126559-ED7E-41E6-B938-93A62EDB02E4 Q38180807-784954F2-765C-47DD-86E4-AC9514DD3020 Q38253844-F6C7EF58-24BD-4631-BAAB-9960A1797F4F

P2860

Adalimumab for the treatment of fistulas in patients with Crohn's disease

http://www.wikidata.org/entity/Q37209889

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adalimumab for the treatment of fistulas in patients with Crohn's disease

@en

Adalimumab for the treatment of fistulas in patients with Crohn's disease.

@nl

type

label

Adalimumab for the treatment of fistulas in patients with Crohn's disease

@en

Adalimumab for the treatment of fistulas in patients with Crohn's disease.

@nl

prefLabel

Adalimumab for the treatment of fistulas in patients with Crohn's disease

@en

Adalimumab for the treatment of fistulas in patients with Crohn's disease.

@nl

P1433

Q37209889-76064FD5-1461-4DD4-9096-F0F416CC0E75

P1476

Q37209889-BDD27979-D32C-4126-B5FA-EEC089AE2FFD

P2093

Q37209889-0186E0A7-5756-450A-A760-D09DBE847C4B

Q37209889-07E9CCA9-D96B-435B-869E-C6907255A046

Q37209889-0DDBD0AD-73EF-46BB-83E6-BE5C918CDDCA

Q37209889-371A87CA-67E1-4EC0-AE60-FACA2D655300

Q37209889-437BE5CA-DFD3-430C-B453-68E4DFF335CE

Q37209889-4DED5302-4B15-4307-8583-824C105842F5

Q37209889-6C029D04-AC6E-4255-80D5-8FDF7D3BA519

Q37209889-6FF7B2B4-6253-4117-A289-D9E42D9C69AB

Q37209889-920EABC0-66DC-43F7-BD17-40D7D2A7A22B

Q37209889-B390270A-B16D-4499-8A4B-796AECDC702F

P2860

Q37209889-342F605F-F9FB-4EFB-AB78-92EC623588E7

Q37209889-62D515D5-9997-4637-9EB4-BFC1F919189F

Q37209889-7C064B27-7385-4AA8-A5C2-C0FD09A6FFEA

Q37209889-9CE95D1A-89CD-405A-A21E-A537955B0D9E

Q37209889-AB4B44CC-4AE9-4EAB-8B2F-D6DC491A9A2A

Q37209889-B2B4ED94-43AE-4617-B4EA-F724057F31AA

Q37209889-D262BD5A-9839-4A34-8ADD-A15EF50C53C2

Q37209889-D8EFBDFA-2ABF-45CF-8AC4-C9B3DC2C8E3F

Q37209889-DCE4296D-408D-4A0E-98FB-EF5B41019690

Q37209889-F2A6DE5C-6B64-482F-A378-458155B47B29

P304

Q37209889-81C6E46F-EA97-4EC1-9A4F-CEAA8364F116

P31

Q37209889-2227933B-6378-470F-8317-82BCBC6700AC

P356

Q37209889-DC86EFBD-EA8F-4024-9FE3-379CBEE46E5E

P407

Q37209889-33A3F023-1F02-41B2-B013-9B1BBC58FE1E

P433

Q37209889-5B27ED90-1179-4BE7-9F01-BDBD21B8C45C

P478

Q37209889-158265E6-72F5-4155-834B-68A692A0EE84

P50

Q37209889-746BD3D1-9F47-44DE-AE1C-18C573917EC7

P577

Q37209889-03F20584-A3E4-41DC-AD1C-A929A4ACC10C

P5875

Q37209889-541CED34-5A42-4393-A293-7EFBB81EAE9D

P698

Q37209889-C11C6551-DFDC-42D3-ACA5-6FB2F842D18C

P921

Q37209889-38DDEF9F-1CE5-4E07-B9B2-C00629570817

Q37209889-4D2C779C-8F80-458F-8628-7EC0D016D2FD

Q37209889-BA9F8EFB-CE92-462C-8A10-78ED824545AE

P932

Q37209889-742C8A90-B790-4435-871C-10FF7FE60584

P356

GUT.2008.159251

P1433

P1476

Adalimumab for the treatment of fistulas in patients with Crohn's disease

@en

P2093

D A Schwartz

http://www.w3.org/2001/XMLSchema#string

G D'Haens

http://www.w3.org/2001/XMLSchema#string

J D Kent

http://www.w3.org/2001/XMLSchema#string

J Li

http://www.w3.org/2001/XMLSchema#string

J-F Colombel

http://www.w3.org/2001/XMLSchema#string

K G Lomax

http://www.w3.org/2001/XMLSchema#string

M A Kamm

http://www.w3.org/2001/XMLSchema#string

P F Pollack

http://www.w3.org/2001/XMLSchema#string

P Rutgeerts

http://www.w3.org/2001/XMLSchema#string

R Enns

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

Certolizumab pegol for the treatment of Crohn's disease

Infliximab maintenance therapy for fistulizing Crohn's disease

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

Infliximab for the treatment of fistulas in patients with Crohn's disease.

Diagnosis and treatment of perianal fistulas in Crohn disease.

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.

Crohn's fistula: current concepts in management.

Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.

P304

940-948

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2008.159251

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

William Jeffery Sandborn

P577

2009-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23989220

http://www.w3.org/2001/XMLSchema#string

P698

19201775

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease

P932

2689393

http://www.w3.org/2001/XMLSchema#string